Nicotine Replacement Therapy Market Share 2021: Global Business Size Analysis by Top Key Players, COVID Impact , Emergin

Comments · 74 Views

The report titled Nicotine Replacement Therapy Market has covered and analyzed the potential of the Worldwide Industry and provides statistics and information on market dynamics, growth factors, key challenges, major drivers & restraints, opportunities and forecast 2027.

Nicotine Replacement Therapy Market | 2021 Impact of COVID-19, Case Study Analysis, Key Opportunities and Major Players, Size, Growth, Share, Regional Analysis With Global Industry Forecast To 2027, The global “Nicotine Replacement Therapy (NRT)” Market is expected to gain momentum by exhibiting a CAGR of 4.2% between 2020 and 2027. This is attributable to increasing incidence of chronic disease such as lung cancer, strokes, and respiratory ailments. Additionally, introduction of innovative products by major companies will favor market growth. This information is published by Fortune Business Insights, in its latest report, titled, “Nicotine Replacement Therapy (NRT) Market Size, Share COVID-19 Impact Analysis, By Type (Gums, Patches, Lozenges, Inhalers, and Others), By Distribution Channel (Hospital Pharmacy, Retail Pharmacy, and Online Pharmacy), and Regional Forecast, 2020-2027.”The report further observes that the market was valued at USD 2.55 billion in 2019 and is projected to reach USD 3.54 billion by 2027.

Major Nicotine Replacement Therapy Market Key players covered in the report include:

  • GlaxoSmithKline plc (U.K, Europe)
  • Johnson Johnson Inc (New Jersey, U.S)
  • Perrigo Company plc (Ireland, Europe)
  • Pierre Fabre SA, Laboratories (France, Europe)
  • Pfizer Inc. (New York, United States)
  • Cipla Limited (Mumbai, India)
  • British American Tobacco Plc (U.K, Europe)
  • Other Players

Get Sample Report Of Nicotine Replacement Therapy Market Report at:

https://www.fortunebusinessinsights.com/enquiry/sample/nicotine-replacement-therapy-nrt-market-103362

Nicotine Replacement Therapy Market Analysis 2021:

Draving Factors :

Increasing Incidence of Chronic Disease to Bolster Growth

According to the Center for Disease Control and Prevention (CDC), smoking cigarettes leads to over 80% to 90% of lung cancer deaths every year in the United States. Tobacco smoke consists of over 7000 chemicals, with over 70 chemicals known to cause cancer in humans. Furthermore, the increasing incidence of chronic ailments is propelling the major companies to introduce innovative nicotine replacement therapy products that aid in to curb the urge to smoke in the people. The growing tobacco addiction in the youth is further driving the demand for the NTR products that will bode well for the growth of the global nicotine replacement therapy market during the forecast period.

REGIONAL INSIGHTS

Growing Smoking Cessation Cases in North America to Propel Demand

Among all regions, North America was worth USD 1.18 billion in 2019 and is expected to hold the highest position in the global nicotine replacement therapy market share during the forecast period. This is attributable to the increasing number of people that desire to quit smoking in the US. For instance, according to the US National Institute of Health, around 70% of the total 46 million Americans smoke, desire to quit smoking. On the other hand, Europe is expected to hold the second position in the market owing to increasing government initiatives to promote anti-smoking campaigns and activities that are expected to drive the demand for nicotine replacement therapy products between 2020 and 2027.

For more information visit : https://www.fortunebusinessinsights.com/nicotine-replacement-therapy-nrt-market-103362